Shaperon - Crunchbase Company Profile & Funding

Q: Where is Shaperon's headquarters?

Shaperon is located in Seoul, Seoul-t'ukpyolsi, South Korea.

Q: Who invested in Shaperon?

Shaperon has 9 investors including Albatross Investment And Nova M Healthcare.

Q: When was the last funding round for Shaperon?

Shaperon closed its last funding round on obfuscated from a Post-IPO Debt round.

Q: How much funding has Shaperon raised to date?

Shaperon has raised obfuscated.

Overview

Shaperon

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Shaperon

CB Rank

86678

Shaperon is a clinical-stage biotech company that develops inflammasome inhibitors.

Founded

obfuscation

Public

Post-IPO Debt

Seoul, Seoul-t'ukpyolsi, South Korea

11-50

shaperon.com

Biopharma

Biotechnology

Funding Rounds

Post-IPO Debt

OBF

obfuscation

Series C

OBF

obfuscation

Key People

Seung-Yong Seong: CEO & Founder

Details

Legal Name

Chaperon Co., Ltd.

Also Known As

샤페론, (주)샤페론

Operating Status

Active

Stock Symbol

KOSDAQ:378800

Company Type

For Profit

Founders

Seung-Yong Seong

Phone Number

82 (0)2 6083 8302

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

NuGel®

A clinical-stage therapeutic candidate for atopic dermatitis targeting inflammasome-mediated inflammation.

NuSepin®

A clinical-stage therapeutic candidate targeting inflammasome pathways for sepsis and COVID-19 related pneumonia treatment.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Debt - Shaperon	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Shaperon	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Shaperon	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Shaperon	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Shaperon	—	obfuscated obfuscation	—	Post-IPO Debt

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Debt - Shaperon	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Shaperon	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Shaperon	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Shaperon	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Shaperon	—	obfuscated obfuscation	—	Post-IPO Debt

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Albatross Investment	—	Series C - Shaperon	—
Albatross Investment	—	Series C - Shaperon	—
Albatross Investment	—	Series C - Shaperon	—
Albatross Investment	—	Series C - Shaperon	—
Albatross Investment	—	Series C - Shaperon	—